Richardson, P., Soiffer, R. J., Antin, J. H., Jin, Z., Kurtzberg, J., Martin, P. L., … Guinan, E. C. (2006). Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. In BLOOD (Vol. 108, pp. 17A-18A). Orlando, FL: AMER SOC HEMATOLOGY.

Richardson, Paul, R. J. Soiffer, J. H. Antin, Z. Jin, J. Kurtzberg, P. L. Martin, G. Steinbach, et al. “Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.” In BLOOD, 108:17A-18A. AMER SOC HEMATOLOGY, 2006.

Richardson P, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, et al. Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. In: BLOOD. AMER SOC HEMATOLOGY; 2006. p. 17A-18A.

Richardson, Paul, et al. “Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.” BLOOD, vol. 108, no. 11, AMER SOC HEMATOLOGY, 2006, pp. 17A-18A.

Richardson P, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen A, Krishnan A, Kernan NA, Avigan D, Spitzer TR, Warren D, Revta C, Wei LJ, Iacobelli M, McDonald GB, Guinan EC. Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. BLOOD. AMER SOC HEMATOLOGY; 2006. p. 17A-18A.